Weiqun Mao - Concepedia

Concepedia

Author

Weiqun Mao

The University of Texas MD Anderson Cancer Center

Also Known As

Mao, Weiqun, W Mao, Weilin Mao, Weiqun Mao, Weixin Mao

70

Publications

1.2K

Citations

23

H-Index

48

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center John Radcliffe Hospital University of Oxford Obstetrics and Gynecology Hospital of Fudan University Second Affiliated Hospital of Xi'an Jiaotong University

WM

About

Weiqun Mao is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	373
2	Engineering	1	1	25
3	Natural Sciences	1	1	36
4	Biochemistry	1	1	36
5	Biomedical Engineering	1	1	25

Weiqun Mao

×

27

Publications

1.2K

Citations

23

H-Index

	Year	Citations
HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy X-F Wen, Gong Yang, Weiqun Mao, Oncogene Antiangiogenic FactorsSignaling PathwayReceptor Tyrosine KinaseImmunologyDistinct Pathways	2006	160
Dasatinib induces autophagic cell death in human ovarian cancer Xiao‐Feng Le, Weiqun Mao, Zhen Lü, Cancer	2010	87
Genes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT Signaling Xiao‐Feng Le, Amy Lammayot, David Gold, Journal of Biological Chemistry	2004	71
A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel Jinhua Zhou, Albandri Alfraidi, Shu Zhang, Clinical Cancer Research	2016	70
Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer Xiao‐Feng Le, Maria Inês Almeida, Weiqun Mao, PLoS ONE	2012	64
Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2 Xiao-Feng Le, Weiqun Mao, Chunhua Lu, Cell Cycle	2008	64
ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts Michele N. Washington, Grace Suh, Aaron Orozco, Cell Death and Disease	2015	62
RAS-related GTPases <i>DIRAS1</i> and <i>DIRAS2</i> induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells Margie N. Sutton, Hailing Yang, Gilbert Y. Huang, Autophagy MitophagyApoptosisImmunologyCell DeathCell Death Mechanisms	2018	56
Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability Hailing Yang, Weiqun Mao, Cristian Rodriguez‐Aguayo, Clinical Cancer Research	2018	54
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers Hailing Yang, Shu Zhang, Yongying Jiang, Clinical Cancer Research	2019	46

Page 1